CLINICAL_TRIALS ClinicalTrials.gov record update

Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02361346
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:01.391413+00:00
Published At: 2022-08-18T00:00:00+00:00
Record Updated At: 2022-08-18
Results Posted At: 2022-08-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-Hodgkin\u0027s B-cell Lymphoma", "Leukemia, Lymphocytic, Chronic, B-Cell", "Small Lymphocytic Leukemia", "Diffuse Large B Cell Lymphoma", "Blood Cancer", "Hematological Malignancy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-08-18"
protocolSection.identificationModule.nctId: "NCT02361346"
protocolSection.identificationModule.officialTitle: "Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-08-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.